Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/10/2025

Alcoholic Cardiomyopathy Diagnosis and Management

Diagnostic Considerations

  • The clinical diagnosis of alcoholic cardiomyopathy can be made when biventricular dysfunction and dilation are persistently observed in a person with a significant history of alcohol use, in the absence of other known causes of myocardial disease, according to the American Heart Association 1.
  • Alcoholic cardiomyopathy typically develops in men aged 30-55 years who have been heavy drinkers for more than 10 years, though patients consuming >90 grams of alcohol daily for >5 years are at risk, as stated by the American College of Cardiology 1.
  • The presence of SVT and NSVT is consistent with alcoholic cardiomyopathy, as arrhythmias are common manifestations of alcohol-induced myocardial damage, according to the American College of Radiology 5, 6.

Management Priorities

  • Total abstinence from alcohol is the cornerstone of treatment and the most critical intervention for reversing myocardial damage, as recommended by the American College of Cardiology 3, 2, 4.
  • Complete abstinence is associated with improvement in depressed left ventricular function, with numerous reports documenting reversibility after cessation of drinking, according to the American Heart Association 3, 2.
  • Without complete abstinence, the 4-year mortality for alcoholic cardiomyopathy approaches 50%, with mortality rates of 40-50% within 3-6 years for those who continue drinking, as stated by the American College of Cardiology 2, 4.
  • Start standard heart failure therapy including ACE inhibitors or ARBs, beta-blockers, mineralocorticoid receptor antagonists, diuretics for volume management, and SGLT2 inhibitors, as recommended by the American College of Cardiology 3, 4.

Genetic Susceptibility

  • Individual susceptibility relates to mean daily alcohol intake, duration of drinking, and genetic predisposition, with some patients developing cardiomyopathy at lower thresholds, according to the American Heart Association 1, 3, 4.